What Is Cortisol Testing

Cortisol testing is the measurement of cortisol, the body's primary glucocorticoid stress hormone, in blood, saliva, or urine. The test evaluates how the adrenal glands produce cortisol across the day and whether the hypothalamic-pituitary-adrenal (HPA) axis is functioning within expected ranges. It is used both in conventional diagnosis of adrenal disorders and in functional medicine to assess chronic stress, fatigue, and hormonal imbalances.

Cortisol governs a wide range of physiological processes: glucose metabolism, immune modulation, blood pressure regulation, inflammatory tone, and the sleep-wake cycle. When cortisol output is chronically elevated or suppressed, or when the normal daily rhythm becomes flattened, cascading effects appear across multiple organ systems. Sustained high cortisol accelerates bone loss, promotes visceral fat deposition, impairs hippocampal function, suppresses immune surveillance, and disrupts sleep architecture. Chronically low cortisol, on the other hand, is associated with fatigue, orthostatic hypotension, and poor stress tolerance.

For anyone focused on healthspan and biological aging, cortisol represents a central node where psychological stress becomes physiological damage. The diurnal cortisol pattern, specifically the ratio between the morning peak and the evening nadir, correlates in epidemiological studies with markers of metabolic health, cognitive performance, and inflammatory load. Testing makes this invisible rhythm visible, creating an objective reference point against which behavioral and lifestyle interventions can be evaluated.

Cortisol is synthesized in the adrenal cortex in response to adrenocorticotropic hormone (ACTH), which is released by the anterior pituitary gland, which in turn responds to corticotropin-releasing hormone (CRH) from the hypothalamus. This three-tier cascade, the HPA axis, operates on a negative feedback loop: rising cortisol signals the hypothalamus and pituitary to reduce CRH and ACTH output. Testing cortisol effectively measures the downstream output of this entire signaling chain.

In blood, cortisol circulates bound to corticosteroid-binding globulin (CBG) and albumin, with only about 5 to 10 percent existing in the free, biologically active form. Salivary cortisol correlates closely with free cortisol because only the unbound fraction diffuses into saliva. This is why salivary testing is considered a better reflection of bioavailable cortisol than total serum cortisol, which includes the bound fraction and can be altered by changes in binding protein levels (as seen with oral contraceptive use or liver conditions). Urinary free cortisol, collected over 24 hours, provides an integrated measure of total cortisol output rather than a snapshot at one time point.

The four-point salivary cortisol test collects samples at specific intervals throughout the day to reconstruct the diurnal curve. A healthy pattern shows a steep rise upon waking (the cortisol awakening response, or CAR), followed by a gradual decline through the afternoon and evening to reach its lowest point around midnight. Deviations from this pattern, such as a blunted morning peak, an elevated evening value, or a flat curve with little variation, each carry distinct clinical implications and point to different underlying mechanisms of HPA axis disruption.

Cortisol testing measures the concentration of cortisol, the principal glucocorticoid hormone, in a biological sample. Serum (blood) cortisol captures both bound and free cortisol, providing a total cortisol value. Salivary cortisol specifically reflects the free, unbound fraction that is biologically active. Urinary free cortisol, collected over 24 hours, integrates total cortisol production across an entire day and is particularly useful for screening conditions of cortisol excess.

Beyond the raw cortisol value, the pattern of cortisol across the day is often the more informative measure. A four-point salivary panel reconstructs the diurnal rhythm: the cortisol awakening response (the sharp rise within 30 to 60 minutes of waking), the midday decline, the afternoon trough, and the nighttime nadir. The shape of this curve, specifically the slope from morning to evening, provides insight into HPA axis regulation that a single value cannot. Some advanced panels, like the DUTCH test, also measure cortisol metabolites (tetrahydrocortisol, tetrahydrocortisone) and the cortisol-to-cortisone ratio, which reflects the activity of the 11-beta-hydroxysteroid dehydrogenase enzymes that interconvert cortisol and its inactive form.

Preparation depends on the testing method, but several principles apply broadly. For morning serum cortisol, most laboratories recommend a fasting draw between 7 and 9 AM, before eating or consuming caffeine. Arrive at the lab in a calm state; rushing or anxiety about the draw can acutely raise cortisol. If possible, sit quietly for 10 to 15 minutes before the blood is collected.

For salivary cortisol panels, avoid eating, drinking (other than plain water), brushing teeth, or using tobacco for at least 30 minutes before each collection. The first sample should be collected within 30 minutes of waking; set an alarm if needed to maintain consistency. Avoid vigorous exercise on the testing day, as intense physical activity can substantially elevate cortisol for hours afterward. Alcohol should be avoided the evening before. Certain medications, including oral contraceptives, corticosteroids (in all forms, including topical and inhaled), and some antidepressants, can affect cortisol levels or cortisol-binding proteins; discuss these with the ordering provider beforehand rather than stopping medications without guidance. Sleeping normally the night before is important, as even one night of poor sleep can shift the diurnal curve.

Morning serum cortisol typically falls between 6 and 23 micrograms per deciliter (mcg/dL), though reference ranges vary by laboratory and assay. Values below 3 mcg/dL raise suspicion for adrenal insufficiency, while values above 23 mcg/dL may prompt evaluation for Cushing's syndrome. However, a single value within the reference range does not rule out HPA axis dysfunction; the shape of the diurnal pattern matters more for subclinical assessment.

In a salivary cortisol panel, the clinically meaningful information lies in the curve rather than any single data point. A healthy pattern shows the highest value in the morning with a progressive decline, reaching its lowest point at night. A blunted morning peak suggests the adrenals are not mounting an adequate awakening response, which is commonly associated with fatigue and difficulty getting started in the morning. An elevated evening cortisol suggests the system is not winding down appropriately, which correlates with nighttime hyperarousal, difficulty falling asleep, and a feeling of being "wired but tired." A flat curve with minimal variation between morning and night is associated with chronic stress exposure, burnout, and fatigue states. Labs typically provide reference ranges for each time point, but interpretation should account for the overall slope and clinical context.

For an initial assessment, a single four-point salivary cortisol panel provides a baseline snapshot of adrenal rhythm. If the results reveal a dysregulated pattern and interventions are initiated (such as sleep optimization, stress management practices, adaptogen use, or changes to exercise intensity), retesting after 8 to 12 weeks gives enough time for the HPA axis to show measurable shifts. Retesting sooner than 6 weeks is unlikely to reveal meaningful changes due to the inherent variability of cortisol output and the time required for behavioral interventions to alter neuroendocrine set points.

For ongoing monitoring in individuals with known HPA axis concerns or those undergoing hormone therapy, testing two to four times per year provides sufficient longitudinal data. Once the diurnal curve normalizes and symptoms resolve, annual testing is generally adequate to confirm the pattern remains stable. Those managing conditions like Cushing's or Addison's disease follow disease-specific monitoring protocols guided by their endocrinologist.

The clinical utility of cortisol testing for diagnosing frank adrenal pathology (Cushing's syndrome, Addison's disease) is well established, supported by decades of endocrinological research and consensus guidelines. For these conditions, morning serum cortisol, late-night salivary cortisol, and 24-hour urinary free cortisol each have defined sensitivity and specificity thresholds that inform clinical decisions.

The use of cortisol testing in functional and integrative medicine contexts, particularly the four-point salivary cortisol curve for assessing subclinical HPA axis dysregulation, has a more mixed evidence base. Multiple observational studies have found associations between flattened diurnal cortisol slopes and outcomes such as chronic fatigue, metabolic syndrome, depression, and reduced immune function. However, standardized reference ranges for salivary cortisol vary between laboratories, and there is no universally agreed-upon definition of "adrenal fatigue" or subclinical HPA axis dysfunction in mainstream endocrinology. The cortisol awakening response has been studied as a biomarker of stress reactivity, with research linking its magnitude to psychosocial stress burden, but day-to-day variability within individuals can be substantial. The DUTCH test, which adds cortisol metabolite data, provides additional granularity, though large-scale validation studies comparing clinical outcomes based on DUTCH-guided interventions versus standard approaches are limited.

Cortisol testing carries no physical risk beyond a standard blood draw when serum testing is used; salivary and urinary methods are noninvasive. The primary risk is misinterpretation. A single cortisol value taken out of context can lead to unnecessary anxiety or inappropriate treatment, especially when normal physiological variation is mistaken for pathology. Factors such as recent illness, shift work, jet lag, medications, and even the stress of the testing situation itself can influence results. Cortisol values should always be interpreted alongside clinical symptoms, medication history, and ideally a full diurnal pattern rather than a single time point. The concept of "adrenal fatigue" as a standalone diagnosis remains contentious; practitioners should distinguish between evidence-based HPA axis evaluation and unvalidated diagnostic labels.